allogeneic HPV-specific CD4+ T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-009902
A preparation of allogeneic T lymphocytes, collected from a haploidentical donor of the patient after vaccination with human papillomavirus (HPV) vaccine series, and depleted of CD8+ lymphocytes, with potential antiviral and antineoplastic activities. Upon administration, allogeneic HPV-specific CD4+ T lymphocytes may induce selective toxicity in HPV-positive cancer cells and other HPV-infected cells. HPV is associated with various cancer cell types. The depletion of CD8+ lymphocytes from the donor cell preparation may lower the risk of graft-versus-host disease (GvHD).
| Identifier | MLC-T-ONC-009902 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | allogeneic HPV-specific CD4+ T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009902",
"term": "allogeneic HPV-specific CD4+ T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of allogeneic T lymphocytes, collected from a haploidentical donor of the patient after vaccination with human papillomavirus (HPV) vaccine series, and depleted of CD8+ lymphocytes, with potential antiviral and antineoplastic activities. Upon administration, allogeneic HPV-specific CD4+ T lymphocytes may induce selective toxicity in HPV-positive cancer cells and other HPV-infected cells. HPV is associated with various cancer cell types. The depletion of CD8+ lymphocytes from the donor cell preparation may lower the risk of graft-versus-host disease (GvHD).",
"synonyms": [
"allogeneic HPV-specific CD4+ T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/allogeneic-hpv-specific-cd4-plus-t-lymphocytes/"
}
Record 788 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.